Medicine & Health

The U.S. Food and Drug Administration said on Aug. 25 that it has authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System, a wearable sensor for people aged 2 and older…

The U.S. Food and Drug Administration has approved Rasonque (daraxonrasib), a tablet taken once a day, for adults with metastatic pancreatic adenocarcinoma, the agency announced Aug. 26. The approval…

The striking thing about psychedelics, clinically, is how long a single afternoon seems to last. A person takes one dose, spends a few hours somewhere strange, and reports feeling different for…

The headline you may have seen this week almost writes itself: lab-grown sperm. It is worth resisting, because the cells that a University of Pennsylvania team actually grew are not sperm. They are…

The U.S. Food and Drug Administration has cleared a Roche blood test intended to help doctors in primary care, not only specialists, check whether a patient's memory problems are likely to involve…

The adult human hippocampus produces new neurons through a chain of cell states, and that chain appears to stall partway in people who had major depression, according to a study of donated brain…

At least 2.1 million people are envenomed by snakebites each year and at least 274,000 die, according to a modeling study published Aug. 25 in PLOS Medicine — the first global re-estimate the same…

The U.S. Food and Drug Administration has approved two regimens built around Ziihera (zanidatamab-hrii) as a first treatment for adults with HER2-positive gastroesophageal adenocarcinoma that cannot…

The message goes out at two in the morning, to the one thing that always answers. Not a friend, not a crisis line: a chatbot. It replies in seconds, never sounds tired, and does not judge. That is a…

Perinatal mortality fell across 17 low- and middle-income countries by a pooled 1.08 deaths per 1,000 births each year (95% CI −1.40 to −0.76) over three decades, according to a study published Aug.…

The U.S. Food and Drug Administration has placed a clinical hold on RGX-121, an experimental gene therapy for Hunter syndrome, and its developer says it no longer expects to resubmit the licensing…

For decades, the story of Alzheimer's has been told from the outside in: sticky plaques between neurons, tangled fibers within them, a slow siege on the brain's wiring. But the plaques and tangles…